PropertyValue
?:abstract
  • INTRODUCTION: The safety of upper gastrointestinal cancer patients in the SARS-CoV-2 outbreak is extremely important and most surgeons need to establish a contingency management. AIM: In this study, we present the surgical outlines of patients suffering from upper gastrointestinal cancers. MATERIALS AND METHODS: Data were obtained from PubMed, Cochrane Database of Controlled Trials, and SCOPUS of reports up to September 2020. RESULTS: The COVID-19 outbreak makes surgical procedures extremely difficult to be performed. The most common criteria to prioritize patients for surgical treatment are stage, tumor biology, presence of tumor-related symptoms, the risk of tumor to become non-resectable, and time interval from neoadjuvant therapy. The multidisciplinary teams can help assigning a priority level to each clinical case. CONCLUSION: We have to continue providing treatment to oncologic patients in the face of COVID-19 uncertainty, with higher caution and responsibility in order to develop a safer and more effective personalized treatment plan.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1007/s12029-020-00557-y
?:journal
  • J_Gastrointest_Cancer
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/aaf461d9352fd72024c6c51e33155f6a24c12841.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7690947.xml.json
?:pmcid
?:pmid
?:pmid
  • 33244705.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Upper Gastrointestinal Cancer Management in the COVID-19 Era: Risk of Infection, Adapted Role of Endoscopy, and Potential Treatment Algorithm Alterations
?:type
?:year
  • 2020-11-26

Metadata

Anon_0  
expand all